Skip to main content
Premium Trial:

Request an Annual Quote

Cell-based Assay Firm Odyssey Thera Raises $2.8M

NEW YORK (GenomeWeb News) – Biotech firm Odyssey Thera has raised $2.8 million and initiated a research service contract with Merck, it announced on Thursday.

The financing, consisting of new funds and debt conversion, will go toward the development and expanded commercialization of the San Ramon, Calif.-based company's technologies and products.

Participants in the round include Merck, HBM Partners, Burrill & Co., and Lonza.

Odyssey has developed technology that measures disease-relevant pathway activity in living human cells. Called protein-fragment complementation assays, or PCA, the technology allows researchers to visualize, quantify, and localize within live cells protein-protein complexes. Proteins can be exogenously expressed at low levels within living cells and their activity can be studied "within their native biological context," the firm said on its website.

"The support from current and new investors will expedite commercialization of Odyssey Thera technologies," John Westwick, president and CEO of the company, said in a statement. "We look forward to supporting Merck and other leading discovery and development programs with these validated capabilities."

Terms of the deal with Merck were not disclosed. The drug firm has collaborated with Odyssey for the past several years, and in 2008 it was the lead investor in an equity funding round by Odyssey.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.